Institut Pasteur

France


 
Quantité totale PI 789
Rang # Quantité totale PI 1 655
Note d'activité PI 3,3/5.0    372
Rang # Activité PI 1 906
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

246 3
89 3
435 13
0
 
Dernier brevet 2025 - Microfluidic device for studying...
Premier brevet 1974 - Purification of tuberculoproteins
Dernière marque 2020 - ICY
Première marque 1970 - PASTEUR

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Method for visualizing at least a zone of an object in at least one interface. The invention con...
Invention Novel nanoparticles of antiretroviral drugs, their preparation and their use for the treatment of...
Invention Anellovirus genome quantification as a biomarker of immune suppression. The present invention re...
Invention Microfluidic device for studying and/or manipulating a study medium and/or at least one micro-obj...
Invention Single domain antibodies directed against human transmembrane- serine protease 2 (tmprss2). The i...
Invention Heterodimer of poxvirus a16 and g9 proteins as an immunogen. The invention relates to an isolated...
Invention Tumor specific antigens and uses thereof. The present invention relates to novel tumor specific p...
Invention Recombinant protein, expression cassette, immunogenic composition and use thereof. The present in...
Invention Method for identifying abnormalities in cells of interest in a biological sample. This invention ...
Invention Variants of terminal deoxynucleotidyl transferase and uses thereof. The present invention relate...
Invention Combined antibodies against sarbecoviruses and uses thereof. The invention relates to combined an...
Invention Adeno-associated virus vector encoding connexin 26 and uses thereof. The present invention relate...
Invention Nucleic acid vaccine against the sars-cov-2 coronavirus. The invention relates to an immunogenic ...
Invention Antigenic tripeptides derived from mycobacterium avium subsp. paratuberculosis s-type strains, de...
Invention Antibodies against orthohantaviruses. Provided herein are hantivirus antibodies. These hantivirus...
Invention Optimized vector for delivery in microbial populations. The present invention relates to a vecto...
Invention Bacteriophage therapy. The subject invention provides a pharmaceutical composition comprising: (...
Invention Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins. The ...
Invention Potentiation of aminoglycosides through activation of carbohydrate transporters. The invention re...
2023 Invention Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurr...
Invention Variants of a dna polymerase of the polx family. The invention relates to variants of a DNA poly...
Invention Generation of antibodies acting as silent and positive allosteric modulators of the alpha7 nicoti...
Invention Polynucleotides and lentiviral vectors expressing non-structural antigens of a flavivirus selecte...
Invention Acidic bacterial exopolysaccharide having immunopotentiating activity. The present invention rela...
Invention Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof. The in...
Invention Methods and systems for generating nucleic acid diversity in crispr-associated genes. Provided ar...
Invention Hsc70-4 in host-induced and spray-induced gene silencing. This disclosure provides proteins, DNA,...
Invention Lentiviral vectors for expression of human papillomavirus (hpv) antigens and its implementation i...
Invention Bacteriophage(s) targeting capsular deficient klebsiella pneumoniae (kp), compositions comprising...
Invention Benzamide adenine dinucleoside compounds and their uses. The inventors have now succeeded in deve...
Invention Method for detecting hpv infection in non-erosive lichen planus. The present invention relates to...
Invention Method for identifying abnormalities in cells of interest in a biological sample. A computer-imp...
Invention Fc-engineered anti-human ige antibodies and methods of use. The present invention relates to the...
2022 Invention Lentiviral vector for expression of human papillomavirus (hpv) antigens and its implementation in...
Invention Luminescent based antigen assay. System for detecting an antigen comprising: —a first fusion pro...
Invention In vitro generation of organized 3d cell structures including head-trunk embryo-like structures, ...
Invention Single domain antibody specific for phosphorylated h2ax and its uses. The present invention rela...
Invention Human neutralizing monoclonal antibodies against sars-cov-2 and uses thereof. The invention rela...
Invention Mntbap and m(iii)n-substituted pyridylporphyrins(mnps)for use in reversing sepsis-induced microgl...
Invention Methods and systems for generating nucleic acid diversity. Provided are methods comprising expre...
Invention Antimicrobial cationic peptoid and n-subtituted peptidic copolymers, preparation and uses thereof...
Invention Measles-hiv or measles-htlv vaccine. The invention relates to recombinant measles virus expressi...
2021 Invention Biomarkers signature(s) for the prevention and early detection of gastric cancer. The invention ...
Invention Gene therapy for treating usher syndrome. The present invention proposes a gene therapy approach...
Invention Protected disaccharides, their process of preparation and their use in the synthesis of zwitterio...
Invention Optimal combination of early biomarkers for infection and sepsis diagnosis in emergency departmen...
Invention High throughput methods and products for sars-cov-2 sero-neutralization assay. Pseudotyped lenti...
Invention Bacterial strains for use as probiotics, compositions thereof, deposited strains and method to id...
2020 P/S Scientific research instruments and apparatus for laboratories, namely, photographic equipment fo...
P/S Scientific research instruments and apparatus for laboratories; downloadable computer software a...
2019 P/S Chemical and biological preparations and substances for scientific and pharmaceutical industry; ...
P/S Chemical and biological preparations and substances intended for science and the pharmaceutical ...
2012 P/S Vaccines for diseases notably cancer, AIDS, plague, rabies, malaria, hepatitis, dengue fever, flu...
2009 P/S Paper, cardboard and goods made from these materials, not included in other classes, namely pack...
2008 P/S Paper, cardboard and goods made of these materials, not included in other classes, namely packag...
2000 P/S Bleaching preparations and other substances for laundry use; preparations for cleaning, polishin...
1999 P/S Chemicals used in industry, science, photography, as well as in agriculture, horticulture and fo...
1998 P/S Préparations pharmaceutiques, nommément médicaments pour le traitement et la prévention de divers...
P/S Services éducatifs nommément, organisation et conduite de colloques, conférences, expositions et ...
1993 P/S periodical publications; namely, scientific journals, research reports and research activity repo...
1987 P/S Produits chimiques destinés à l'industrie, aux sciences. Produits pharmaceutiques, vétérinaires.
1986 P/S Heat-stable vaccine against yellow fever.
P/S Produits pharmaceutiques, vaccin et, plus particulièrement, vaccin antigrippal.
1984 P/S Réactifs de laboratoires à usage biomédical. Produits pharmaceutiques et vétérinaires.
1975 P/S Produits chimiques destinés à l'industrie, la science, la photographie, l'agriculture, l'horticu...
1972 P/S Préparations chimiques utilisées dans la fabrication pharmaceutique ou médicale ou réalisées dans...
1970 P/S Produits chimiques et compositions pour l'industrie pharmaceutique, chimique, alimentaire, pour ...